The results indicate that model performance is significantly influenced by data modality and that artificial intelligence may serve as a valuable computational tool to support clinical breast cancer diagnosis workflow.
Abstract
Breast cancer is one of the leading causes of cancer-related mortality worldwide, and despite advances in clinical diagnosis, challenges such as inconclusive imaging results and inter-observer variability highlight the need for complementary computational approaches to support early and accurate detection. In this study, we provide an overview of several machine learning (ML) and deep learning (DL) algorithms used for breast cancer detection with structured clinical data and imaging data. We applied ML models to structured clinical data which included Wisconsin Breast Cancer Dataset, CSAW-CC dataset and SEER database using Random Forest, Decision Tree, Logistic Regression, Gradient Boosting, and Bayesian classifier models. DL models, specifically Convolutional Neural Networks (CNN), ResNet50, VGG16, and DenseNet, were utilized in mammography, histopathology, and ultrasound datasets. The experimental results show that the DL models outperformed ML models in image classification tasks, obtaining accuracy rates of 97.88% for histopathological images and 92.00% for ultrasound data. However, ensemble-based and probabilistic ML models achieved strong performance on structured clinical data, with predictive accuracy of up to 98%. All performance metrics are reported with 95% confidence intervals.Model calibration was assessed using the Expected Calibration Error (ECE) and reliability diagrams. Logistic Regression, Gradient Boosting, and Random Forest produced the best-calibrated probability estimates among the structured-data classifiers, while the transfer-learning-based deep convolutional architectures were well calibrated on the histopathology imaging datasets. Calibration was comparatively weaker for Decision Tree and Naive Bayes among the structured-data classifiers, as well as for the from-scratch CNN baseline and some deep learning models evaluated on the smaller BUSI dataset. The results indicate that model performance is significantly influenced by data modality and that artificial intelligence may serve as a valuable computational tool to support clinical breast cancer diagnosis workflow. Further prospective validation using clinical data across diverse patient populations will be essential to confirm the robustness, interpretability, and generalizability of these findings.
The review concludes that optimized, explainable, and adversarially robust ensemble frameworks, validated through multi-center clinical trials, represent the most promising direction for translating deep learning research into dependable and deployable breast cancer detection systems.
Abraham Temilade Olumide, Obe Olumide Olayinka, A. Emmanuel et al.· INTERNATIONAL JOURNAL OF MAT...· 0 citations
Breast cancer is one of the most common cancers among women worldwide with more than 2.3 million new breast cancer cases diagnosed each year [1], where early detection has a significantly positive effect on patient survival rates. Examination of histopathological features remains the gold standard [2] in the diagnosis...
R. Gurumoorthy, H. Rajyashree, R. M. Pandeeswari et al.· International Journal of Dru...· 0 citations
This systematic review synthesises peer-reviewed studies published between 2014 and 2025 that exclusively applied DL techniques to breast MRI for cancer classification, prediction, or segmentation and demonstrates that DL models consistently achieve high diagnostic performance and have the potential to enhance radiolog...
Qais Al-Azzam, W. Balachandran, Ziad Hunaiti· AI in Medicine· 0 citations
The most important contributions from this review are a quantitative comparison of efficiency for edge versus cloud deployment, detection of dataset bias, and practical recommendations regarding infrastructure, regulatory pathways, and privacy-preserving federated learning.
Kennedy T. Chitiza, Abid Yahya, Nechibvute Action et al.· Discover Data· 0 citations
A robust soft-voting ensemble-based deep learning model for automatic binary breast cancer identification using histopathology images can achieve effective classification performance without excessive attention complexity while keeping clear visual evidence.
M. Tiar, Nadjiba Terki, Z. Kahhoul et al.· Cluster Computing· 0 citations
Background: Breast cancer is the leading cause of cancer-related mortality in females, with 2.3 million new cases diagnosed annually. Machine learning (ML) algorithms have the potential to improve diagnostic accuracy through the analysis of high-dimensional data. However, the lack of standardized benchmarks across diff...
Ali A. Hamad, Naaman Omar· Charmo Journal of Natural Sc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.